An Intermediate Size Expanded Access Protocol of Elamipretide | MicrobiomeTrials← Back to trialsNCT04689360
An Intermediate Size Expanded Access Protocol of Elamipretide
AVAILABLEEXPANDED_ACCESS
Other microbiome trials you might be interested in
Friedreich Ataxia
An open label study designed to evaluate the safety, PK, PD, and clinical effects of long-term daily administration of C…
Los Angeles, United StatesEst. completion Jan 2027
SepsisCritical IllnessImmunosuppressionMODSMitochondrial DiseasesDysbiosisγδ T Cells
This prospective observational cohort study investigates the subset-specific metabolic adaptation and functional remodel…
Wuhan, ChinaEst. completion Apr 15, 2027